Back to funds
View filing
Avidity Partners Management LP
hedge fundUpdated 27 days agoManaged by Avidity Partners Management Lp • Latest filing Q2 2026
Portfolio value
$624.4M
Q2 2026
Filings
14
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
-54.4%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 14 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $3B |
| Q2 2023 | $2.9B |
| Q3 2023 | $2.5B |
| Q4 2023 | $2.7B |
| Q1 2024 | $3.1B |
| Q2 2024 | $2.4B |
| Q3 2024 | $2B |
| Q4 2024 | $1B |
| Q1 2025 | $524.7M |
| Q2 2025 | $502M |
| Q3 2025 | $439.4M |
| Q4 2025 | $346.7M |
| Q1 2026 | $441.9M |
| Q2 2026 | $624.4M |
Top holdings
45 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | D DNTH DIANTHUS THERAPEUTICS INC | $205.1M | 2.10M | 32.85% | — |
| 2 | C CGON CG ONCOLOGY INC | $99.4M | 1.40M | 15.92% | — |
| 3 | O ORKA ORUKA THERAPEUTICS INC | $72.4M | 760.4K | 11.59% | — |
| 4 | J JBIO JADE BIOSCIENCES INC | $37.8M | 1.70M | 6.05% | — |
| 5 | E ELVN ENLIVEN THERAPEUTICS INC | $27.9M | 550.0K | 4.47% | — |
| 6 | ? N/A PERSPECTIVE THERAPEUTICS INC | $21.5M | 6.30M | 3.44% | — |
| 7 | A AKTS AKTIS ONCOLOGY INC | $15.6M | 484.2K | 2.50% | — |
| 8 | P PVLA PALVELLA THERAPEUTICS INC NE | $10.7M | 70.0K | 1.71% | — |
| 9 | M MOBI MOBIA MED INC | $10.7M | 798.3K | 1.71% | — |
| 10 | R RGEN REPLIGEN CORP | $10.6M | 77.8K | 1.70% | — |
| 11 | ? N/A IMMUNIC INC | $10.3M | 669.9K | 1.65% | — |
| 12 | S SENS SENSEONICS HLDGS INC | $9.1M | 1.60M | 1.46% | — |
| 13 | K KPTI KARYOPHARM THERAPEUTICS INC | $9M | 924.5K | 1.45% | — |
| 14 | T TEVJF TEVA PHARMACEUTICAL INDS LTD | $6.8M | 200.0K | 1.09% | — |
| 15 | D DXCM DEXCOM INC | $6.7M | 100.0K | 1.08% | — |
| 16 | T TEM TEMPUS AI INC | $6.1M | 105.0K | 0.97% | — |
| 17 | M MDT MEDTRONIC PLC | $5.5M | 70.0K | 0.88% | — |
| 18 | V VIR VIR BIOTECHNOLOGY INC | $5.3M | 519.3K | 0.85% | — |
| 19 | G GPCR STRUCTURE THERAPEUTICS INC | $5.3M | 98.0K | 0.84% | — |
| 20 | E EHC ENCOMPASS HEALTH CORP | $4.2M | 42.0K | 0.68% | — |